AI-generated analysis. Always verify with the original filing.
Biogen Inc. filed an 8-K on March 11, 2026, with Items listed as N/A. The external context indicates Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, occurring on March 11.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 11,